Safety and Mechanism of Action of Licensed Vaccine Adjuvants.
Rambe, Dirga Sakti; Giudice, Giuseppe Del; Rossi, Stefania; Sanicas, Melvin.
Artículo en Inglés | IMSEAR | ID: sea-168003
Documentos relacionados
Safety and Mechanism of Action of Licensed Vaccine Adjuvants.
Suitability and perspectives on using recombinant insect cells for the production of virus-like particles.
[Heterogeneity in psychiatry training in Europe: competition or collaboration?]
Correlative imaging using super-resolution fluorescence microscopy and soft X-ray tomography at cryogenic temperatures provides a new way to assess virosome solutions for vaccine development.
Adverse events of vaccines and the consequences of non-vaccination: a critical review
[Mental Health Situation of Sex Workers in Europe: a Scoping Review].
[The Image of Doctors in Europe: A Comparison of Countries].
Optimized production of HIV-1 virus-like particles by transient transfection in CAP-T cells.
[HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
Interaction of Human Parainfluenza Virus Type 3 Nucleoprotein with Matrix Protein Mediates Internal Viral Protein Assembly.